Tage Honoré
Director/Board Member at VANDA PHARMACEUTICALS INC.
Net worth: 287 813 $ as of 30/04/2024
Tage Honoré active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VANDA PHARMACEUTICALS INC. | Director/Board Member | 15/03/2023 | - |
| Independent Dir/Board Member | 15/03/2023 | - | |
Avicenna Biosciences, Inc.
 Avicenna Biosciences, Inc. BiotechnologyHealth Technology Avicenna Biosciences, Inc. is an American biotechnology company that focuses on redesigning and optimizing drug candidates. | Corporate Officer/Principal | 01/01/2020 | - |
Career history of Tage Honoré
Former positions of Tage Honoré
| Companies | Position | Start | End |
|---|---|---|---|
Dep-Xplora ApS
 Dep-Xplora ApS BiotechnologyHealth Technology Dep-Xplora ApS provides drugs in the development of depots for joint injections. Its non-steroidal anti-inflammatory drugs are widely used as rescue medicine to relieve moderate to severe postoperative pain after minor joint surgery and to alleviate inflammatory pain associated with various arthritis conditions. The firms prodrug approach taken enables establishment of drug concentration to manage pain and inflammation at the site of action and at the same time minimizes the risk of systemic adverse events. The company was founded by Jens Hansen and Claus Selch Larsen in 2012 and is headquartered in Lejre, Denmark. | Chairman | 01/02/2013 | 01/03/2019 |
Training of Tage Honoré
| University of Copenhagen | Doctorate Degree |
Statistics
International
| United States | 3 |
| Denmark | 3 |
Operational
| Chairman | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VANDA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Dep-Xplora ApS
Dep-Xplora ApS BiotechnologyHealth Technology Dep-Xplora ApS provides drugs in the development of depots for joint injections. Its non-steroidal anti-inflammatory drugs are widely used as rescue medicine to relieve moderate to severe postoperative pain after minor joint surgery and to alleviate inflammatory pain associated with various arthritis conditions. The firms prodrug approach taken enables establishment of drug concentration to manage pain and inflammation at the site of action and at the same time minimizes the risk of systemic adverse events. The company was founded by Jens Hansen and Claus Selch Larsen in 2012 and is headquartered in Lejre, Denmark. | Health Technology |
Avicenna Biosciences, Inc.
Avicenna Biosciences, Inc. BiotechnologyHealth Technology Avicenna Biosciences, Inc. is an American biotechnology company that focuses on redesigning and optimizing drug candidates. | Health Technology |
- Stock Market
- Insiders
- Tage Honoré
- Experience
